Higher rate scale for the contribution on pharmaceutical companies' promotion expenses
Article 20 of the 2002 Social Security Financing Act rewrites the scale of Article L. 245-2 of the Social Security Code. Depending on the ratio of prospecting and information expenses aimed at doctors to turnover, the bracket rates rise from 9.5%, 15%, 18% and 21% to 9.5%, 17.5%, 25.5% and 31%. The allowance for generic and orphan medicines rises from 30% to 40% of the related turnover, and an allowance of 3% of medical sales representatives' pay is created. These rules apply to the contribution due on 1 December 2002.
Measure originators
No official estimate found for this measure.
Measure impact
Laboratories spending a large share of turnover on promotion to doctors pay more: the top bracket rate rises from 21% to 31%. The government's initial bill provided for 10.5%, 17%, 25% and 31%. The Senate reports a yield of FRF 1.329 billion in 2000.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
Entrée en vigueur de la mesure et mise en œuvre par l'administration
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP
Debate and vote
Debate and vote
Débat et vote en séance publique à l'Assemblée nationale, ou engagement de la responsabilité du Gouvernement (article 49.3)